NEW

FDA Plans eMDR System Updates

The U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH) plans to update the FDA’s electronic medical device reporting (eMDR) system to reflect updates to the FDA Form 3500A and other system enhancements. The FDA Form 3500A is...

FDA Clears GE Healthcare’s Deep Learning-Based MR Image Reconstruction

GE Healthcare has announced U.S. FDA 510(k) clearance of AIR Recon DL. “This pioneering technology, using a deep learning-based neural network, improves the patient experience through shorter scan times while also increasing diagnostic confidence with better image...

GlobalData: Impact of COVID-19 on diagnostic imaging not as severe compared to other areas

The impact of COVID-19 on diagnostic imaging (DI) procedures will not be as severe compared to other therapy areas, such as aesthetics and dental, since only 38.7% of these procedures are elective and expected to drop due to the COVID-19 pandemic, according to...

FDA Approves Cerianna

PETNET Solutions Inc., a Siemens Healthineers company, and Zionexa USA, a wholly owned subsidiary of Zionexa SAS, have announced that the Food and Drug Administration (FDA) has approved Cerianna (fluoroestradiol F 18) injection for intravenous use. Cerianna...

Laurel Bridge Software Introduces AI Workflow Suite

Laurel Bridge Software announces the new Laurel Bridge AI Workflow Suite that enhances the ability of healthcare providers and AI developers to integrate artificial intelligence (AI) algorithms into their clinical workflows. Visit Laurel Bridge Software at the upcoming RSNA 2019 Annual Meeting in Booth 8132 – North Hall, to discuss how its can help your organization enhance the interoperability among your disparate imaging IT systems and maximize the clinical utility of AI algorithms.

Organizations planning or implementing AI algorithms should consider how to automatically identify, fetch, anonymize and deliver current and relevant prior studies to AI algorithms and post-processing applications, as well as how to reidentify and store AI algorithm results in an archive. While much of the effort surrounding AI in medical imaging is currently focused on algorithm development, clinical utility will rely upon the seamless and reliable integration of AI algorithms into existing clinical reading workflows.

The Laurel Bridge AI Workflow Suite can manage these tasks automatically by leveraging functionality in the Laurel Bridge Compass, Navigator and Waypoint solutions. The Laurel Bridge AI Workflow Suite, which can integrate on-premises and cloud-based AI algorithms into existing clinical workflows, is HIPAA-compliant and adheres to DICOM standards. This enables the delivery of AI algorithm results to a PACS, VNA and EMR. The Laurel Bridge solution supports radiology and other DICOM applications such as cardiology and ophthalmology.

The Laurel Bridge AI Workflow Suite provides:

  • Integration of study data between AI algorithms and existing clinical systems and workflows
  • Seamless interoperability between local facilities and cloud-based AI algorithms
  • Standards-based interoperability with third-party applications and clinical systems

“Many customers have requested workflow integration assistance with their AI algorithms,” says Jeff Blair, president of Laurel Bridge Software. “Until the AI algorithm workflow is fully automated, adoption into clinical workflow will lag.”

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *